Navigation Links
Europe 'punches above its weight' in biomedical research, despite limited funding
Date:9/28/2011

European biomedical research is advancing at a great pace compared to the relatively small funds available, and with more funding, it could do better. This is one of the main conclusions from a new White Paper, published by the European Medical Research Councils (EMRC) the European Science Foundation's membership organisation for all medical research councils in Europe.

The EMRC White Paper, entitled 'A Stronger Biomedical Research for a Better European Future', will be launched at a meeting held in Strasbourg on 29 September 2011 and follows a previous White Paper, "Present Status and Future Strategy for Medical Research In Europe" published four years ago.

Calling for global collaboration and cohesion in biomedical research, the White Paper analyses the current state of biomedical research within Europe compared with its international collaborators, together with an assessment of new challenges faced in Europe, including changing patterns of diseases, ageing populations and growing cost of healthcare.

Professor Liselotte Hjgaard, Chair of the European Medical Research Councils said, "We believe that this White Paper presents a powerful case for the future strategy of biomedical research in Europe, which will benefit society in many ways and will improve the quality of life for the citizens of Europe and the rest of the world and meet the difficult challenges we are facing".

The White Paper makes five key recommendations which should underlie future policy and strategy for biomedical research in Europe:

  1. Citizens and patients should be closely engaged with biomedical research
  2. The results of biomedical research should be rapidly and efficiently brought to the patient
  3. Biomedical research should be conducted with high quality in an open, honest and transparent way
  4. European biomedical research should be conducted within a global context
  5. Investment should be increased to create the right world-class biomedical research

Author, Dr. Thierry Damerval, Deputy Director of Inserm (France), said: "With investment in biomedical research yielding a return of 40% per year, adequate funding and best practice for biomedical research are not only essential to secure health and welfare in Europe and the rest of the world, but they also makes sound economic sense".


'/>"/>

Contact: Emma Knott, Kaizo
Emma.knott@kaizo.net
44-020-731-764-715
European Science Foundation
Source:Eurekalert

Related biology news :

1. Europe rallies behind nanotechnology to wean world from fossil fuels
2. IOF calls on European citizens to stand tall and speak out for their bones
3. IronKey Opens New European Office
4. European researchers harness unique properties of boron to develop new drugs and diagnostics
5. Vidaza receives positve opinion from European CHMP
6. The MDS foundation supports vidazas recommendation for European approval
7. European biodiversity and ecosystem scientists merge and gear up for long-term research
8. Overfishing threatens European bluefin tuna
9. 11,000 alien species invade Europe
10. Europe cores in EUROCORES: Ocean drilling in EuroMARC
11. European ancestry increases breast cancer risk among Latinas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... Calif. , Nov. 14, 2016 /PRNewswire/ ... biometric identification market, Frost & Sullivan recognizes ... & Sullivan Award for Visionary Innovation Leadership. ... in the biometric identification market by pioneering ... verification solution for instant, seamless, and non-invasive ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... 2016 , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing ... President, Jake Lubinski will be traveling to Germany on December 6th. Mr. Lubinski ... Karlsruhe to discuss the benefits of a viscoelastic total disc replacement. , AxioMed ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/4/2016)... 2016  In five studies being presented today during ... and Exposition in San Diego , ... the delivery of life-saving treatments to patients with a ... to carry therapies directly to the sites in the ... a substantial advantage over traditional, systemic methods. The studies ...
(Date:12/2/2016)... THOUSAND OAKS, Calif. , Dec. 2, 2016 ... AGN ) today announced the submission of a ... for ABP 215, a biosimilar candidate to Avastin ® ... biosimilar application submitted to the EMA. "The ... milestone as Amgen seeks to expand our oncology portfolio," said ...
Breaking Biology Technology: